Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Polyether ionophore, autophagy inhibitor.
Mycotoxin produced by Fusarium; ER agonist.
Endogenous catecholamine precursor, also found ...
Morpholine derivative.
Endogenous precursor to all steroid hormones; T...
USP1 inhibitor
Macrocyclic lactone.
Polymethoxy flavonoid found in citrus fruits.
Bisphosphonate, chelating agent.
Carotene pigment found in red and green fruits ...
Trichothecene mycotoxin produced by Fusarium.
AurKB/C inhibitor.
STING inhibitor
PLK1 inhibitor.
p38 MAPK inhibitor.
Camptothecin analog; topoisomerase I inhibitor,...
Fatty acid found in dairy products; HDAC inhibi...
Laminin-derived nonapeptide.
Naturally occuring isothiocyanate found in broc...
EZH2 HMT inhibitor.